Alfresa deals with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices.
Business Model:
Revenue: $20B
Employees: 10,001-999,999
Address: 1-1-3, Chiyoda-ku
City: Otemachi
State: tōkyō prefecture
Zip: 100-0004
Country: JP
Alfresa Holdings engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, and Manufacturing. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, and medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells general over-the-counter drugs. The Manufacturing segment manufactures and markets products in the fields of pharmaceuticals, diagnostic reagents, and medical devices. The company was founded on September 29, 2003, and is headquartered in Tokyo, Japan.
Contact Phone:
Contact Email:
Listed Exchange:
TYO
IPO Date:
9/29/2003
Ticker Symbol:
2784
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2020 | PharmaBio | Corporate Round | - |
7/2020 | Integrity Healthcare Japan | Corporate Round | 0 |
4/2020 | Human Life CORD | Corporate Round | - |
2/2020 | Quantum Operation | Corporate Round | 0 |
1/2021 | Metcela | Series B | 0 |
5/2021 | donut robotics | Venture Round | - |
5/2021 | donut robotics | Venture Round | - |
1/2021 | Metcela | Series B | 0 |
7/2020 | Integrity Healthcare Japan | Corporate Round | 0 |
6/2020 | PharmaBio | Corporate Round | - |
4/2020 | Human Life CORD | Corporate Round | - |
2/2020 | Quantum Operation | Corporate Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|